Form 4: Arteris COO Sells Shares Under Pre-Arranged 10b5-1 Plan

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold a total of 12,978 shares of common stock in early September 2025 under a pre-arranged 10b5-1 trading plan.

Summary

• Laurent R. Moll, Chief Operating Officer of Arteris, Inc. (AIP), reported sales of common stock.
• A total of 12,978 shares were sold across three transactions in September 2025.
• On September 5, 2025, 4,698 shares were sold at a weighted average price of $8.8045, with prices ranging from $8.69 to $8.93.
• On September 8, 2025, 8,129 shares were sold at a weighted average price of $8.7434, with prices ranging from $8.54 to $8.97.
• On September 9, 2025, 151 shares were sold at a price of $8.61.
• All transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2025.
• Following these transactions, Moll beneficially owns 386,401 shares of Arteris, Inc. common stock.

Sentiment

Score: 6

Explanation: The sale of shares by a Chief Operating Officer is generally viewed as neutral to slightly negative, but the existence of a pre-arranged 10b5-1 trading plan mitigates concerns about discretionary selling, leading to a neutral-to-slightly positive interpretation.

Positives

• The sales were conducted under a pre-arranged 10b5-1 trading plan, adopted on March 12, 2025, which indicates the transactions were scheduled in advance and not based on recent non-public information.

Negatives

• Insider selling, even under a 10b5-1 plan, reduces the direct ownership stake of a key executive, which can sometimes be interpreted as a slight reduction in alignment with shareholder interests.

Risks

• While mitigated by the 10b5-1 plan, significant or repeated insider selling could potentially be perceived by the market as a signal of reduced confidence in the company's near-term prospects, impacting investor sentiment.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

This insider transaction report is specific to Arteris, Inc. and its Chief Operating Officer, Laurent R. Moll, and does not provide broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders may perceive insider selling as a slight negative, but the 10b5-1 plan reduces the implication of a lack of confidence, suggesting a planned liquidity event rather than a reaction to new information.

Key Dates

Recommendation

The insider sale was conducted under a pre-arranged 10b5-1 trading plan, which suggests a planned diversification or liquidity event rather than a reaction to new negative information. Therefore, it does not warrant a change in investment thesis based solely on this filing.

Keywords

Arteris, AIP, insider trading, Form 4, stock sale, 10b5-1 plan, beneficial ownership, Chief Operating Officer